269 related articles for article (PubMed ID: 22703928)
1. Adrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner.
Cresci S; Dorn GW; Jones PG; Beitelshees AL; Li AY; Lenzini PA; Province MA; Spertus JA; Lanfear DE
J Am Coll Cardiol; 2012 Sep; 60(10):898-907. PubMed ID: 22703928
[TBL] [Abstract][Full Text] [Related]
2. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
Lanfear DE; Jones PG; Marsh S; Cresci S; McLeod HL; Spertus JA
JAMA; 2005 Sep; 294(12):1526-33. PubMed ID: 16189366
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic modifiers of long-term survival in heart failure.
Cresci S; Kelly RJ; Cappola TP; Diwan A; Dries D; Kardia SL; Dorn GW
J Am Coll Cardiol; 2009 Jul; 54(5):432-44. PubMed ID: 19628119
[TBL] [Abstract][Full Text] [Related]
4. Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.
Cresci S; Jones PG; Sucharov CC; Marsh S; Lanfear DE; Garsa A; Courtois M; Weinheimer CJ; Wu J; Province MA; Kelly DP; McLeod HL; Spertus JA
Pharmacogenomics; 2008 Oct; 9(10):1403-17. PubMed ID: 18855529
[TBL] [Abstract][Full Text] [Related]
5. Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.
Parikh KS; Fiuzat M; Davis G; Neely M; Blain-Nelson P; Whellan DJ; Abraham WT; Adams KF; Felker GM; Liggett SB; O'Connor CM; Bristow MR
Circ Genom Precis Med; 2018 Aug; 11(8):e002210. PubMed ID: 30354340
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.
Sehnert AJ; Daniels SE; Elashoff M; Wingrove JA; Burrow CR; Horne B; Muhlestein JB; Donahue M; Liggett SB; Anderson JL; Kraus WE
J Am Coll Cardiol; 2008 Aug; 52(8):644-51. PubMed ID: 18702968
[TBL] [Abstract][Full Text] [Related]
7. Association of β-Adrenergic Receptor Gene Polymorphisms With Acute Coronary Syndrome and Cardiovascular Risk Factors in an Arab Population.
El-Menyar A; Rizk NM; Asim M; Al-Thani H; Elgendy A; Al-Suwaidi J
Angiology; 2016 Sep; 67(8):762-71. PubMed ID: 26602751
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.
Castaño-Amores C; Antúnez-Rodríguez A; Pozo-Agundo A; García-Rodríguez S; Martínez-González LJ; Dávila-Fajardo CL
Biomed Pharmacother; 2023 Dec; 169():115869. PubMed ID: 37952358
[TBL] [Abstract][Full Text] [Related]
9. GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans.
Kurnik D; Cunningham AJ; Sofowora GG; Kohli U; Li C; Friedman EA; Muszkat M; Menon UB; Wood AJ; Stein CM
Pharmacogenomics; 2009 Oct; 10(10):1581-7. PubMed ID: 19842931
[TBL] [Abstract][Full Text] [Related]
10. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.
Liggett SB; Cresci S; Kelly RJ; Syed FM; Matkovich SJ; Hahn HS; Diwan A; Martini JS; Sparks L; Parekh RR; Spertus JA; Koch WJ; Kardia SL; Dorn GW
Nat Med; 2008 May; 14(5):510-7. PubMed ID: 18425130
[TBL] [Abstract][Full Text] [Related]
11. β-Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In-Hospital and 12-Month Outcome: Results From the GULF-RACE 2 (Gulf Registry of Acute Coronary Events-2).
Abi Khalil C; AlHabib KF; Singh R; Asaad N; Alfaleh H; Alsheikh-Ali AA; Sulaiman K; Alshamiri M; Alshaer F; AlMahmeed W; Al Suwaidi J
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29263035
[TBL] [Abstract][Full Text] [Related]
12. Beta2-adrenergic receptor genotype and survival after acute coronary syndrome.
Jackson CM; Lipworth BJ
JAMA; 2006 Feb; 295(7):757; author reply 757-8. PubMed ID: 16478896
[No Abstract] [Full Text] [Related]
13. Beta2-adrenergic receptor genotype and survival after acute coronary syndrome.
Snyder EM; Johnson BD
JAMA; 2006 Feb; 295(7):756-7; author reply 757-8. PubMed ID: 16478895
[No Abstract] [Full Text] [Related]
14. β2-Adrenergic receptor promoter haplotype influences the severity of acute viral respiratory tract infection during infancy: a prospective cohort study.
Wu P; Larkin EK; Reiss SS; Carroll KN; Summar ML; Minton PA; Woodward KB; Liu Z; Islam JY; Hartert TV; Moore PE
BMC Med Genet; 2015 Sep; 16():82. PubMed ID: 26369942
[TBL] [Abstract][Full Text] [Related]
15. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
[TBL] [Abstract][Full Text] [Related]
16. beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.
Pacanowski MA; Gong Y; Cooper-Dehoff RM; Schork NJ; Shriver MD; Langaee TY; Pepine CJ; Johnson JA;
Clin Pharmacol Ther; 2008 Dec; 84(6):715-21. PubMed ID: 18615004
[TBL] [Abstract][Full Text] [Related]
17. Effects of GRK5 and ADRB1 polymorphisms influence on systolic heart failure.
Kang S; Hong X; Ruan CW; Yu P; Yu SS; Chen M; Zhang DF; Fan HM; Liu ZM
J Transl Med; 2015 Feb; 13():44. PubMed ID: 25638254
[TBL] [Abstract][Full Text] [Related]
18. APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.
Mukamal KJ; Tremaglio J; Friedman DJ; Ix JH; Kuller LH; Tracy RP; Pollak MR
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):398-403. PubMed ID: 26634651
[TBL] [Abstract][Full Text] [Related]
19. Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study.
Ortega VE; Hawkins GA; Moore WC; Hastie AT; Ampleford EJ; Busse WW; Castro M; Chardon D; Erzurum SC; Israel E; Montealegre F; Wenzel SE; Peters SP; Meyers DA; Bleecker ER
Lancet Respir Med; 2014 Mar; 2(3):204-13. PubMed ID: 24621682
[TBL] [Abstract][Full Text] [Related]
20. Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome.
Oni-Orisan A; Cresci S; Jones PG; Theken KN; Spertus JA; Lee CR
Prostaglandins Other Lipid Mediat; 2018 Sep; 138():15-22. PubMed ID: 30096423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
